Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
JN.1.10ORF1abChan-ORF1abCGCATACAGTCTTRCAGGCT20501622016239F-4484.57China
EG.2.5ORF1abChan-ORF1abCGCATACAGTCTTRCAGGCT20501622016239F-4484.57China
GW.4ORF1abChan-ORF1abCGCATACAGTCTTRCAGGCT20501622016239F-4484.57China
HC.4ORF1abChan-ORF1abCGCATACAGTCTTRCAGGCT20501622016239F-4484.57China
GS.1ORF1abChan-ORF1abCGCATACAGTCTTRCAGGCT20501622016239F-4484.57China
GS.3ORF1abChan-ORF1abCGCATACAGTCTTRCAGGCT20501622016239F-4484.57China
BA.1.1.16ORF1abChan-ORF1abCGCATACAGTCTTRCAGGCT20501622016239F-4484.57China
B.1.587ORF1abChan-ORF1abCGCATACAGTCTTRCAGGCT20501622016239F-4484.57China
B.1.232ORF1abChan-ORF1abCGCATACAGTCTTRCAGGCT20501622016239F-4484.57China
B.1.333ORF1abChan-ORF1abCGCATACAGTCTTRCAGGCT20501622016239F-4484.57China
BA.5.2.34ORF1abChan-ORF1abCGCATACAGTCTTRCAGGCT20501622016239F-4484.57China
CM.7.1ORF1abChan-ORF1abCGCATACAGTCTTRCAGGCT20501622016239F-4484.57China
FA.1ORF1abChan-ORF1abCGCATACAGTCTTRCAGGCT20501622016239F-4484.57China
B.1.1.523ORF1abChan-ORF1abCGCATACAGTCTTRCAGGCT20501622016239F-4484.57China
BA.2.31.1ORF1abChan-ORF1abCGCATACAGTCTTRCAGGCT20501622016239F-4484.57China
P.7NHKU-NCGAAGGTGTGACTTCCATG1952.632925429236R-4478.8Hong Kong
N.8NHKU-NCGAAGGTGTGACTTCCATG1952.632925429236R-4478.8Hong Kong
AY.29.2 (Delta)NHKU-NCGAAGGTGTGACTTCCATG1952.632925429236R-4478.8Hong Kong
B.1.160.27NHKU-NCGAAGGTGTGACTTCCATG1952.632925429236R-4478.8Hong Kong
B.1.177.68NHKU-NCGAAGGTGTGACTTCCATG1952.632925429236R-4478.8Hong Kong
AY.79 (Delta)NHKU-NCGAAGGTGTGACTTCCATG1952.632925429236R-4478.8Hong Kong
P.1.9 (Gamma)NHKU-NCGAAGGTGTGACTTCCATG1952.632925429236R-4478.8Hong Kong
B.1.165NHKU-NCGAAGGTGTGACTTCCATG1952.632925429236R-4478.8Hong Kong
B.1.444NHKU-NCGAAGGTGTGACTTCCATG1952.632925429236R-4478.8Hong Kong
B.1.1.371NHKU-NCGAAGGTGTGACTTCCATG1952.632925429236R-4478.8Hong Kong
AY.121.1 (Delta)NHKU-NCGAAGGTGTGACTTCCATG1952.632925429236R-4478.8Hong Kong
AY.4.10 (Delta)NHKU-NCGAAGGTGTGACTTCCATG1952.632925429236R-4478.8Hong Kong
B.1.177.26NHKU-NCGAAGGTGTGACTTCCATG1952.632925429236R-4478.8Hong Kong
Q.6 (Alpha)NHKU-NCGAAGGTGTGACTTCCATG1952.632925429236R-4478.8Hong Kong
B.45SChan-SCCTACTAAATTAAATGATCTCTGCTTTACT30302271222741F-4477.88China
B.1.258.7SChan-SCCTACTAAATTAAATGATCTCTGCTTTACT30302271222741F-4477.88China
XBB.2.11.1SChan-SCCTACTAAATTAAATGATCTCTGCTTTACT30302271222741F-4477.88China
CY.2NNIH-TH_NCCCCACTGCGTTCTCCATT1957.892837628358R-4438.27Thailand
B.1.267ORF1abCharité-ORF1bGTGARATGGTCATGTGTGGCGG2254.551543115452F-4436.15Germany
B.1.188ORF1abChan-ORF1abGTGTGATGTTGAWATGACATGGTC2441.671635316330R-4427.27China
B.1.258.23NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-4388.79US
BA.2.75.3NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-4388.79US
B.1.473NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-4388.79US
BQ.1.15.2NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-4388.79US
B.1.1.121NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-4388.79US
B.1.355NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-4388.79US
BA.5.2.2NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-4388.79US
BF.12NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-4388.79US
BA.5.1.3NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-4388.79US
BA.2.13.1NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-4388.79US
BA.5.1.24NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-4388.79US
CK.3NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-4388.79US
BA.5.2.31NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-4388.79US
B.1.232NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-4388.79US
BA.5.1.7NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-4388.79US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used